[
    [
        {
            "time": "",
            "original_text": "港证监禁止盈透证券处理一客户资产 涉嫌华熙生物内幕交易",
            "features": {
                "keywords": [
                    "港证监",
                    "盈透证券",
                    "客户资产",
                    "华熙生物",
                    "内幕交易"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港证监禁止盈透证券处理一客户资产 涉嫌华熙生物内幕交易",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]